Endotelix is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Endotelix is dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome, including diagnostic tests and therapies.

Location

Avenue de la Roseraie 64, Geneva, Switzerland

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2019
  • Number of employees in Switzerland
    1-9
Key business